tradingkey.logo

MiMedx Group Inc

MDXG

7.150USD

+0.210+3.03%
收盘 09/18, 16:00美东报价延迟15分钟
1.06B总市值
32.87市盈率 TTM

MiMedx Group Inc

7.150

+0.210+3.03%
关于 MiMedx Group Inc 公司
MiMedx Group, Inc. 是一家胎盘生物制剂公司。该公司致力于开发和分销具有专利保护工艺的胎盘组织异体移植,服务于医疗保健的多个领域。其产品组合类别包括伤口护理产品以及外科和其他产品。其伤口护理产品包括 EPIFIX、EPICORD 和 EPIEFFECT,这些产品均用于外用,例如用于高级伤口护理应用。其外科和其他产品包括 AMNIOFIX、AMNIOCORD 和 AMNIOEFFECT,这些产品适用于各种应用和外科环境,包括下肢修复、整形外科、血管外科和多种骨科修复和重建。该公司的平台技术包括源自人胎盘膜的组织异体移植、源自人脐带的组织异体移植以及源自人胎盘的颗粒细胞外基质。
公司简介
公司代码MDXG
公司名称MiMedx Group Inc
上市日期Aug 20, 2007
CEOMr. Joseph H. (Joe) Capper
员工数量837
证券类型Ordinary Share
年结日Aug 20
公司地址1775 W Oak Commons Court, Ne
城市MARIETTA
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编30062
电话17706519100
网址https://mimedx.com/
公司代码MDXG
上市日期Aug 20, 2007
CEOMr. Joseph H. (Joe) Capper
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
89.04K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
Mr. William A. (Bill) Hawkins, III
Mr. William A. (Bill) Hawkins, III
Independent Director
Independent Director
--
--
Mr. Douglas C. Rice
Mr. Douglas C. Rice
Chief Financial Officer
Chief Financial Officer
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
89.04K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
业务USD
名称
营收
占比
Advanced Wound Care
56.07M
63.57%
Surgical
32.13M
36.43%
暂无数据
业务
地区
业务USD
名称
营收
占比
Advanced Wound Care
56.07M
63.57%
Surgical
32.13M
36.43%
股东统计
更新时间: 8月15日 周五
更新时间: 8月15日 周五
持股股东
股东类型
持股股东
持股股东
占比
EW Healthcare Partners
19.06%
BlackRock Institutional Trust Company, N.A.
5.95%
Trigran Investments, Inc.
5.67%
The Vanguard Group, Inc.
4.69%
Paradigm Capital Management, Inc.
3.01%
其他
61.63%
持股股东
持股股东
占比
EW Healthcare Partners
19.06%
BlackRock Institutional Trust Company, N.A.
5.95%
Trigran Investments, Inc.
5.67%
The Vanguard Group, Inc.
4.69%
Paradigm Capital Management, Inc.
3.01%
其他
61.63%
股东类型
持股股东
占比
Venture Capital
19.08%
Investment Advisor
18.90%
Investment Advisor/Hedge Fund
18.84%
Hedge Fund
11.98%
Research Firm
1.89%
Individual Investor
1.83%
Pension Fund
0.49%
Bank and Trust
0.35%
Insurance Company
0.03%
其他
26.60%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
451
106.45M
71.95%
-3.98M
2025Q1
460
106.92M
72.40%
-5.30M
2024Q4
455
107.57M
73.21%
-3.01M
2024Q3
429
103.18M
70.48%
-6.90M
2024Q2
424
100.59M
68.44%
-3.52M
2024Q1
405
106.53M
74.65%
+1.42M
2023Q4
391
100.91M
86.85%
+27.80M
2023Q3
385
72.00M
62.20%
-22.83M
2023Q2
375
65.55M
56.85%
-21.21M
2023Q1
361
82.89M
72.72%
-885.21K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
EW Healthcare Partners
28.20M
19.09%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
8.58M
5.81%
+179.59K
+2.14%
Mar 31, 2025
Trigran Investments, Inc.
7.60M
5.15%
-21.96K
-0.29%
Mar 31, 2025
The Vanguard Group, Inc.
6.69M
4.53%
+5.46K
+0.08%
Mar 31, 2025
Paradigm Capital Management, Inc.
4.68M
3.17%
-2.73K
-0.06%
Mar 31, 2025
State Street Global Advisors (US)
3.46M
2.34%
+189.21K
+5.79%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.91M
1.97%
+133.11K
+4.79%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.01M
1.36%
+206.79K
+11.47%
Mar 31, 2025
Renaissance Technologies LLC
1.93M
1.31%
+125.72K
+6.97%
Mar 31, 2025
Cannell Capital, LLC
2.13M
1.44%
-1.51M
-41.39%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
KeyAI